Newsroom

For press inquiries, please contact press@CAImmunologyBond.com

Press Release

Historic Immunology Medical Research & Cures Initiative Officially Qualifies for California’s November 2026 Ballot

The Immunology Medical Research & Cures Initiative officially qualified for the November 2026 statewide ballot, with county officials reporting having certified more than 601,317 signatures needed to qualify via random sample. This bond measure gives California voters the opportunity to advance life-saving research and cures for the most debilitating diseases facing millions of California families.

Press Release

Supporters Submit Signatures to Qualify Historic Immunology Bond for California’s November 2026 Ballot

Today, supporters of the California Immunology Research & Cures Initiative announced they have submitted over 900,000 signatures to qualify the measure for the November 2026 statewide ballot. This $8.4 billion bond will fund California-based nonprofit universities and research institutions to conduct immunology research to develop cutting-edge immunotherapies to prevent and cure debilitating diseases like cancer, Alzheimer’s, and heart disease in our lifetime.

Memorial Sloan Kettering Cancer Center

FDA Approves Adding Durvalumab Immunotherapy to Prevent Stomach and Esophageal Cancer Recurrence

A clinical trial led by researchers at Memorial Sloan Kettering Cancer Center (MSK) has demonstrated a powerful new approach to help prevent cancer from coming back after treatment for stomach cancer, cancer of the lower portion of the esophagus, and gastroesophageal junction (GEJ) cancer.

Reuters

Immune system breakthrough wins Nobel medicine prize for US, Japan scientists

American scientists Mary Brunkow and Fred Ramsdell and Shimon Sakaguchi from Japan won the 2025 Nobel Prize in Physiology or Medicine on Monday for work shedding light on how the immune system spares healthy cells, creating openings for possible new autoimmune disease and cancer treatments.